Table III.

Pooled analysis of the association of BAALC expression with specific FAB subtypes of AML.

	Random effects model overall effect				Fixed effects model overall effect
FAB subtype	OR	95% CI	P-value	Heterogeneity I2, %	OR	95% CI	P-value	Heterogeneity I2, %
M0	2.95	1.29–6.78	0.01	0.0	2.35	0.96–5.77	0.06	0.0
M1	2.20	1.58–3.05	<0.01	0.0	2.22	1.58–3.10	<0.01	0.0
M2	1.36	1.06–1.77	0.02	59.1	1.38	0.87–2.17	0.19	59.1
M4	0.62	0.45–0.87	0.01	43.6	0.56	0.34–0.95	0.03	43.6
M5	0.27	0.15–0.50	<0.01	47.1	0.32	0.23–0.46	<0.01	47.1
M6	0.85	0.44–1.65	0.63	0.0	0.83	0.40–1.73	0.63	0.0

BAALC, brain and acute leukemia, cytoplasmic; FAB, French-American-British; AML, acute myeloid leukemia; OR, odds ratio; CI, confidence interval.